Immunological responses to SARS-CoV-2 vaccines in kidney transplant recipients

This publication has 11 references indexed in Scilit:

• Safety and Immunogenicity of a Third Dose of SARS-CoV-2 Vaccine in Solid Organ Transplant Recipients: A Case Series
  Annals of Internal Medicine, 2021
• Antibody and T Cell Response to SARS-CoV-2 Messenger RNA BNT162b2 Vaccine in Kidney Transplant Recipients and Hemodialysis Patients
  Journal of the American Society of Nephrology, 2021
• Safety and Immunogenicity of Anti–SARS-CoV-2 Messenger RNA Vaccines in Recipients of Solid Organ Transplants
  Annals of Internal Medicine, 2021
• Three Doses of an mRNA Covid-19 Vaccine in Solid-Organ Transplant Recipients
  New England Journal of Medicine, 2021
• Weak anti–SARS-CoV-2 antibody response after the first injection of an mRNA COVID-19 vaccine in kidney transplant recipients
  Kidney International, 2021
• BNT162b2 vaccine induces neutralizing antibodies and poly-specific T cells in humans
  Nature, 2021
• Cellular and humoral response after MRNA-1273 SARS-CoV-2 vaccine in kidney transplant recipients
  American Journal of Transplantation, 2021
• Comparative systematic review and meta-analysis of reactogenicity, immunogenicity and efficacy of vaccines against SARS-CoV-2
  npj Vaccines, 2021
• Antibody Response to 2-Dose SARS-CoV-2 mRNA Vaccine Series in Solid Organ Transplant Recipients
  JAMA, 2021
• Poor Anti-SARS-CoV-2 Humoral and T-cell Responses After 2 Injections of mRNA Vaccine in Kidney Transplant Recipients Treated With Belatacept
  Transplantation, 2021